Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

MiraeAsset Financial Group

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 7
Average round size
info
The average size of a deal this fund participated in
$154M
Portfolio companies 7
Lead investments 0
Exits 1
Key employees Soon

Areas of investment

  • Biotechnology
  • Genetics
  • Drug Discovery
  • Sharing Economy
  • Rental

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of MiraeAsset Financial Group:
Typical Co-investors
MiraeAsset Financial Group is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after MiraeAsset Financial Group:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
3W Partners Missouri, Saint Louis, United States
Altos Venture Allschwil, Basel-Landschaft, Switzerland
Blue Wave Innovation Capital County Dublin, Dublin, Ireland
Calumet Venture Fund Madison, United States, Wisconsin
Chiesi Ventures Boston, Massachusetts, United States
Estrella Roja -
Gladium Gothenburg, Sweden, Vastra Gotaland
Harvest Global Investments China, Hong Kong, Hong Kong Island
Ideal Ventures -
Invitalia Italy, Lazio, Roma
JSW Ventures India, Maharashtra, Mumbai
Leaguer Group China, Guangdong, Shenzhen
Lloyd's Lab England, London, United Kingdom
Mix Capital -
Nu Horizons Investments -
OK Gang Capital -
OSJL LLC -
Plastilin -
RGB Capital California, San Diego, United States
Silver Tiger Capital Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Septerna

Biotechnology
$150M11 Jul 2023 San Francisco, California, United States

Grover

Consumer Electronics
PaaS
Rental
Sharing Economy
Subscription Service
$110M07 Apr 2022 Berlin, Berlin, Germany

Abogen Biosciences

Biotechnology
Life Science
$300M29 Nov 2021 Gusu District, Jiangsu, China

MindwareWorks

Artificial Intelligence
CRM
Software
Wireless
$3M15 Oct 2021 Seoul, Seoul-t'ukpyolsi, South Korea

Biopharma
Biotechnology
Health Care
Therapeutics
$120M22 Mar 2021 Shanghai, China

4D Molecular Therapeutics

Biotechnology
Drug Discovery
Genetics
$75M16 Jun 2020 California, United States

BioNTech

$325M09 Jul 2019 -

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent MiraeAsset Financial Group?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 7
Average round size 154M
Peak activity year 2021
Lead investments 0
Exits 1
Group Appearance index 0.86

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Septerna

Biotechnology
$150M11 Jul 2023 San Francisco, California, United States

Grover

Consumer Electronics
PaaS
Rental
Sharing Economy
Subscription Service
$110M07 Apr 2022 Berlin, Berlin, Germany

Abogen Biosciences

Biotechnology
Life Science
$300M29 Nov 2021 Gusu District, Jiangsu, China

MindwareWorks

Artificial Intelligence
CRM
Software
Wireless
$3M15 Oct 2021 Seoul, Seoul-t'ukpyolsi, South Korea

Biopharma
Biotechnology
Health Care
Therapeutics
$120M22 Mar 2021 Shanghai, China

4D Molecular Therapeutics

Biotechnology
Drug Discovery
Genetics
$75M16 Jun 2020 California, United States

BioNTech

$325M09 Jul 2019 -
Crunchbase icon

Content report

The following text will be sent to our editors: